Health Economics & Outcome Research: Open Access

ISSN - 2471-268X

Dr. Jayant Kelwade

MD, DNB Endocrinology, Endocrinologist, Alexis Hospital, Nagpur, India


  • Review Article   
    Cost efficacy of S-Amlodipine vs Racemic Amlodipine in Hypertension Management
    Author(s): Dr. Uttio Gupta*, Dr. Jayant Kelwade, Dr. Sreejith M, Dr. Jacob Thomas and Dr. Sejao Vidyasindhu

    Background: An equivalent efficacy compared with racemic amlodipine with reduced or insignificant peripheral edema makes S-amlodipine a costeffective treatment alternative in hypertension. S-amlodipine has also been proven to be effective, safe, and well-tolerated even when used as combination therapy with other antihypertensive agents. S-amlodipine has added benefits in optimizing atherogenic lipids and reduces cardiovascular outcomes. The present review was performed to assess the health economics of the use of S-amlodipine in hypertension. Methods: Authors conducted a systematic review of published literature to evaluate the health economics and outcomes research of the use of S-amlodipine in hypertension treatment. The Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines were used to report this review. .. View More»
    DOI: 10.35248/2471-268X.21.7.177

    Abstract HTML PDF